TransCode Therapeutics Statistics

NASDAQ: RNAZHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.71-0.05 (-2.84%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

TransCode Therapeutics by the numbers

TransCode Therapeutics has a market capitalization of $29.0 million based on 16.93M shares outstanding. With trailing EPS of $-52.06, TransCode Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 33.5% below its 50-day average and 74.3% below its 200-day average.

Average daily trading volume is 50.80K shares, or about $86,865 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

RNAZ valuation vs. peer median

RNAZ compared with the median of 8 peer companies
Metric	RNAZ	Peer median	Difference
Market cap	$28.95M	$27.88M	+4%
Avg. volume	50.80K	647.22K	-92%

Peer median across 8 companies: IGC, MIRA, IMMP, CNTX, NXTC, SHPH, MCRB, ABVC.

Valuation

Market cap: $28.95M
P/E (TTM): —
Forward P/E: —
EPS (TTM): $-52.06
Shares outstanding: 16.93M

Price and trading

Previous close: 1.76
Open: 1.80
Day range: 1.68 – 1.80
52-week range: 1.52 – 15.94
52-week change: -85.60%
50-day moving average: 2.57
200-day moving average: 6.64
Beta: —
Volume: 27.83K
Average volume: 50.80K

Dividends and events

Annual dividend: None
Dividend yield: —
Ex-dividend date: —
Next earnings date: —

Additional statistics

Market Cap: 28.95M
Forward Pe: -2.85
Eps: -52.06
Dividend Yield: 0.00%
Dividend Rate: 0.00
Week52 High: 15.94
Week52 Low: 1.52
Avg Volume: 50,798.00
Shares Outstanding: 16.93M
Ma50: 2.57
Ma200: 6.64
Pct From52w High: -89.27%
Pct From52w Low: 12.50%